Novo Nordisk A/S
Novo Nordisk A/S (NONOF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NONOF · as of Jun 8, 2026
Key Statistics
Explore Novo Nordisk A/S Data
nonof stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 72.0%
Competitors & Peers
nonof competitorsNONOF
AZNCF
CMXHF
CSLLY
ESLOF
FSNUYStock Performance
Full HistoryAbout Novo Nordisk A/S
Novo Nordisk A/S operates as a prominent global pharmaceutical firm, dedicated to the discovery, development, production, and distribution of a wide array of medicinal products. Its extensive operatio…
what is novo nordisk a/s · nonof stock overview · novo nordisk a/s company profile · who is novo nordisk a/s ceo · nonof OTC · novo nordisk a/s headquarters · novo nordisk a/s business segments
About Stock Overview & Key Data
Novo Nordisk A/S (NONOF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 7, 2010. As of the latest trading session, NONOF stock price is $41.25, with a market capitalization of $183.3B. The stock has returned -43.91% over the past 12 months and -17.88% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Novo Nordisk A/S stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Novo Nordisk A/S reported revenue of $308.4B and net income of $102.2B. For detailed data — including Novo Nordisk A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novo Nordisk A/S (NONOF) stock price is $41.25. The stock is traded on OTC under the ticker symbol NONOF. The 52-week range is $34.00 – $82.50.